Haider pointed out that investors paid close attention to CEO Albert Bourla’s comments on tariffs. Bourla said the government’s primary concern is national security — ensuring that essential ...

You can reach Adam on Signal at stataf.54. It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire ...

Albert Bourla, Pfizer chairman and CEO ... freight experts Billy Joel cancels all shows after brain disorder diagnosis 9 Lies About Homeowners Insurance That Just Aren't True Early shark sightings ...

Genetics is just one of several factors thought to influence personality disorder development. Life experiences, family dynamics, coping mechanisms, and social learning may all be contributing ...

No cluster D of personality disorders is currently featured in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, text revision (DSM-5-TR). Only clusters A, B, and C are ...

Pfizer Chairman and CEO Albert Bourla joins 'Mad Money' host Jim Cramer to talk quarterly results, what's in the pipeline, and more. Harris Retakes Lead in Critical Swing State: Polling Average ...

Pfizer Inc. PFE CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the pharmaceutical giant’s struggling share price and refine its ...

Pfizer (NYSE:PFE) CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant. Bourla and at least ...

Pfizer’s chief executive, Dr. Albert Bourla, said the drug-making company is in a “very advanced stage” and should know by the end of October whether the coronavirus vaccine they are ...

Antisocial personality disorder (ASPD) is a mental health condition that affects how a person thinks, behaves, perceives things, and relates with others. The condition causes prolonged patterns of ...

When Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when Bourla ...